Prothrombin kringle-2 activates cultured rat brain microglia

Area of Science:

• Neuroimmunology
• Molecular Biology
• Cellular Signaling

Background:

• Microglia are key immune cells in the central nervous system (CNS) that activate upon brain injury.
• Prothrombin is a precursor to thrombin, an enzyme involved in blood clotting.
• Understanding microglial activation pathways is crucial for addressing neuroinflammatory conditions.

Purpose of the Study:

• To investigate the role of prothrombin in activating rat brain microglia.
• To determine if prothrombin's protease activity is necessary for microglial activation.
• To identify specific domains of prothrombin responsible for inducing microglial responses.

Main Methods:

• Treatment of rat brain microglia with prothrombin and its domain, kringle-2.
• Measurement of nitric oxide (NO) release and mRNA expression of inflammatory markers (iNOS, IL-1beta, TNF-alpha).
• Inhibition studies using hirudin (thrombin inhibitor) and pathway-specific inhibitors (MAPK, NF-kappaB, PKC, PLC).

Main Results:

• Prothrombin induced NO release and inflammatory gene expression in microglia.
• This effect was independent of thrombin's protease activity.
• The kringle-2 domain of prothrombin mimicked prothrombin's effects.
• Both prothrombin and kringle-2 activated similar intracellular signaling pathways, including MAPK and NF-kappaB.

Conclusions:

• Prothrombin is capable of activating microglia, independent of its thrombin activity.
• The kringle-2 domain is sufficient to activate microglia and induce inflammatory responses.
• Prothrombin and kringle-2 activate microglia via conserved intracellular signaling cascades, offering potential therapeutic targets.